Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A man had both alopecia areata and lichen planus, which is uncommon.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Women with early onset androgenetic alopecia have worse lipid profiles.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.